Denovo Sciences
Yerevan · Founded 2019
About Denovo Sciences
Denovo Sciences creates novel therapeutics using state of the art AI technologies. They use computational simulations for directed chemical space searches, drug design, and the generation of polypharmacological molecules.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $626.2K
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: https://www.denovosciences.ai/
- Phone: +374(60)-740-044
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/denovo-sciences-8129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.